Insiders · Profile

Congleton Jon

Chief Executive Officer at Mineralys Therapeutics. Filing since 11 Aug 2023. CIK 0001644975

Company

Date

Role

Action

Shares

Amount

Of holding

MLYS Mineralys Therapeutics, Inc.

30 Sep 2026

Chief Executive Officer

Sold on a plan

75,000

$1.91M

12.4%

MLYS Mineralys Therapeutics, Inc.

13 Jul 2026

Chief Executive Officer

Sold on a plan

10,700

$291.44K

1.7%

MLYS Mineralys Therapeutics, Inc.

30 Jun 2026

Chief Executive Officer

Sold on a plan

75,000

$1.96M

10.9%

MLYS Mineralys Therapeutics, Inc.

13 Apr 2026

Chief Executive Officer

Sold on a plan

15,730

$421.98K

2.2%

MLYS Mineralys Therapeutics, Inc.

31 Mar 2026

Chief Executive Officer

Sold on a plan

75,000

$1.97M

9.6%

MLYS Mineralys Therapeutics, Inc.

12 Jan 2026

Chief Executive Officer

Sold on a plan

16,236

$529.64K

2.5%

MLYS Mineralys Therapeutics, Inc.

11 Nov 2025

Chief Executive Officer

Sold at will

200,000

$9.09M

24.1%

MLYS Mineralys Therapeutics, Inc.

13 Oct 2025

Chief Executive Officer

Sold on a plan

15,100

$644.33K

1.8%

MLYS Mineralys Therapeutics, Inc.

11 Jul 2025

Chief Executive Officer

Sold on a plan

15,884

$230.43K

1.8%

MLYS Mineralys Therapeutics, Inc.

11 Apr 2025

Chief Executive Officer

Sold on a plan

15,319

$186.80K

1.7%

MLYS Mineralys Therapeutics, Inc.

13 Jan 2025

Chief Executive Officer

Sold on a plan

18,333

$166.08K

2.0%

MLYS Mineralys Therapeutics, Inc.

11 Oct 2024

Chief Executive Officer

Sold on a plan

15,271

$206.43K

1.7%

MLYS Mineralys Therapeutics, Inc.

11 Jul 2024

Chief Executive Officer

Sold on a plan

15,746

$210.08K

1.7%

MLYS Mineralys Therapeutics, Inc.

20 Jun 2024

Chief Executive Officer

Sold on a plan

14,940

$175.24K

1.6%

MLYS Mineralys Therapeutics, Inc.

18 Jun 2024

Chief Executive Officer

Sold on a plan

16,607

$199.07K

1.7%

MLYS Mineralys Therapeutics, Inc.

17 Jun 2024

Chief Executive Officer

Sold on a plan

17,766

$217.71K

1.8%

MLYS Mineralys Therapeutics, Inc.

14 Jun 2024

Chief Executive Officer

Sold on a plan

16,229

$203.16K

1.6%

MLYS Mineralys Therapeutics, Inc.

13 Jun 2024

Chief Executive Officer

Sold on a plan

39,961

$509.03K

3.9%

MLYS Mineralys Therapeutics, Inc.

12 Jun 2024

Chief Executive Officer

Sold on a plan

16,607

$212.01K

1.6%

MLYS Mineralys Therapeutics, Inc.

22 Nov 2023

Chief Executive Officer

Bought

4,250

$25.36K

0.4%

MLYS Mineralys Therapeutics, Inc.

6 Sep 2023

Chief Executive Officer

Bought

2,250

$27.18K

0.2%

MLYS Mineralys Therapeutics, Inc.

17 Aug 2023

Chief Executive Officer

Bought

2,250

$27.23K

0.2%

MLYS Mineralys Therapeutics, Inc.

11 Aug 2023

Chief Executive Officer

Bought

2,000

$25.78K

0.2%

23 decisions on file.